Umbilical cord blood CD34 +cell-derived progeny produces human leukocyte antigen-G molecules with immuno-modulatory functions

Human Immunology

Volumn 73, Issue 2, 2012, Pages 150-155

  Buzzi, Marina ^a   Alviano, Francesco ^a   Campioni, Diana ^b   Stignani, Marina ^c   Melchiorri, Loredana ^c   Rotola, Antonella ^c   Tazzari, Pierluigi ^a   Ricci, Francesca ^a   Vaselli, Cristiana ^a   Terzi, Adriana ^a   Pagliaro, Pasquale P ^a   Cuneo, Antonio ^b   Lanza, Francesco ^d   Bontadini, Andrea ^a   Baricordi, Olavio R ^c   Rizzo, Roberta ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d CREMONA HOSPITAL   (Italy)

Author keywords

CD34 + cell; HLA G; Immunoregulation; Transplant; Umbilical cord blood

Indexed keywords

CD34 ANTIGEN; HLA G ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DOSE RESPONSE; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NORMAL HUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD34; CELL PROLIFERATION; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION; HLA-G ANTIGENS; HUMANS; IMMUNOLOGIC FACTORS; PREGNANCY;

EID: 84856328619     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.003     Document Type: Article

References (30)

1. Escalón M.P., Komanduri K.V. Cord blood transplantation: Evolving strategies to improve engraftment and immune reconstitution. Curr Opin Oncol 2010, 22:122-129.
2. Gluckman E. History of cord blood transplantation. Bone Marrow Transplant 2009, 4:621-626.
3. Forraz N., McGuckin C.P. The umbilical cord: A rich and ethical stem cell source to advance regenerative medicine. Cell Prolif 2011, 44:60-69.
4. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339:1565-1577.
5. Rocha V., Wagner J.E., Sobocinski K.A., Klein J.P., Zhang M.J., Horowitz M.M., et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling: Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000, 342:1846-1854.
6. Rocha V., Cornish J., Sievers E.L., Filipovich A., Locatelli F., Peters C., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001, 97:2962-2971.
7. Eapen M., Rubinstein P., Zhang M.J., Stevens C., Kurtzberg J., Scaradavou A., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study. Lancet 2007, 369:1947-1954.
8. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.J., Champlin R.E., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004, 351:2265-2275.
9. Tipnis S., Viswanathan C., Majumdar A.S. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: Role of B7-H1 and IDO. Immunol Cell Biol 2010, 88:795-806.
10. López A.S., Alegre E., LeMaoult J., Carosella E., González A. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. Mol Immunol 2006, 43:2151-2160.
11. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862-4870.
12. Baricordi O.R., Stignani M., Melchiorri L., Rizzo R. HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets 2008, 7:67-74.
13. Hackmon R., Hallak M., Krup M., Weitzman D., Sheiner E., Kaplan B., et al. HLA-G antigen and parturition: Maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004, 19:404-409.
14. Kirszenbaum M., Moreau P., Teyssier M., Lafon C., Gluckman E., Dausset J., et al. Evidence for the presence of the alternatively spliced HLA-G mRNA forms in human mononuclear cells from peripheral blood and umbilical cord blood. Hum Immunol 1995, 43:237-241.
15. Román A., Rodríguez M., Herraiz M.A., Jordá J., Cervera I., Peñaloza J., et al. Heterogeneous expression of HLA-G1, -G2, -G5, -G6, and -G7 in myeloid and plasmacytoid dendritic cells isolated from umbilical cord blood. Hum Immunol 2009, 70:104-109.
16. Ogata H., Bradley G.W., Inaba M., Ogata N., Ikehara S., Good R.A. Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice. Proc Natl Acad Sci U S A 1995, 92:5945-5949.
17. Roodman G.D., LeMaistre C.F., Clark G.M., Page C.P., Newcomb T.F., Knight W.A. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy. Bone Marrow Transplant 1987, 2:165-173.
18. Campioni D., Lo Monaco A., Lanza F., Moretti S., Ferrari L., Fotinidi M., et al. CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis. Haematologica 2008, 93:1233-1237.
19. + cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hemopoietic engrafment in patients undergoing autologous peripheral blood stem cell transplantation. Exp Hematol 2001, 29:1-10.
20. Rebmann V., Lemaoult J., Rouas-Freiss N., Carosella E.D., Grosse-Wilde H. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen. Hum Immunol 2004, 66:853-863.
21. Fainardi E., Rizzo R., Melchiorri L., Stignani M., Castellazzi M., Caniatti M.L., et al. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 2007, 192:219-225.
22. Poláková K., Russ G. Expression of the non classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma 2000, 47:342-348.
23. Ongaro A., Stignani M., Pellati A., Melchiorri L., Massari L., Caruso G., et al. Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis. Hum Immunol 2010, 71:342-350.
24. Lindaman A., Dowden A., Zavazava N. Soluble HLA-G molecules induce apoptosis in natural killer cells. Am J Reprod Immunol 2006, 56:68-76.
25. Rizzo R., Dal Canto M.B., Stignani M., Fadini R., Fumagalli D., Renzini M.M., Borgatti M., Gambari R., Baricordi O.R. Production of sHLA-G molecules by in vitro matured cumulus-oocyte complex. Int J Mol Med 2009, 24:523-530.
26. Rizzo R., Campioni D., Stignani M., Melchiorri L., Bagnara G.P., Bonsi L., et al. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy 2008, 10:364-375.
27. - cells in cord blood and bone marrow. Blood 1995, 86:3745-3753.
28. Ulbrecht M., Maier S., Hofmeister V., Falk C.S., Brooks A.G., McMaster M.T., et al. Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands. Hum Immunol 2004, 65:200-208.
29. Agaugué S., Carosella E.D., Rouas-Freiss N. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. Blood 2011, 117:7021-7031.
30. Ning H., Yang F., Jiang M., Hu L., Feng K., Zhang J., et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study. Leukemia 2008, 22:593-599.